BIGBEAR
PHARMACEUTICAL
Cabozantinib is an oral multi-targeted tyrosine kinase inhibitor with broad-spectrum anticancer activity.
AuthenticGuaranteeFast DeliveryPrivacy Cabozantinib, known as the "troublemaker" among targeted therapies, can simultaneously inhibit multiple key targets including VEGFR, C-MET, ···【More】
Update: 23 Jun,2026Source: BigbearViews: 116
In the generic cabozantinib market, the capsule formulation launched by Lao Big Bear Pharmaceutical is highly favored for its affordable price and rel···【More】
Update: 23 Jun,2026Source: BigbearViews: 126
The generic cabozantinib produced by BigBearPharma in Laos, marketed under the brand name CABODX, offers a new regulatory-approved treatment option fo···【More】
Update: 23 Jun,2026Source: BigbearViews: 127
The price of cabozantinib fluctuates significantly due to factors such as dosage, version, and purchase channel. Generic drugs are relatively cheaper,···【More】
Update: 20 Mar,2026Source: BigbearViews: 135
The price of cabozantinib varies significantly depending on factors such as dosage, regional policies, and purchasing channels. Currently, this drug i···【More】
Update: 20 Mar,2026Source: BigbearViews: 137
Cabozantinib plays an important role in the treatment of malignant tumors such as advanced renal cell carcinoma and hepatocellular carcinoma by precis···【More】
Update: 16 Mar,2026Source: BigbearViews: 130
Cabozantinib is a multitargeted small-molecule tyrosine kinase inhibitor. By inhibiting multiple targets related to tumor growth and angiogenesis, it ···【More】
Update: 16 Mar,2026Source: BigbearViews: 138
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos
